drugset / Trial / NCT06828757

Clinical Study of Nanocrystalline Megestrol in Malnourished Patients With First-Line Non-Small Cell Lung Cancer

NCT06828757

Phase 3 Not yet recruiting 94 enrolled Hunan Province Tumor Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This prospective interventional clinical study evaluates the efficacy of nanocrystalline megestrol combined with standard care in improving appetite and weight compared to standard care alone in first-line treatment of NSCLC.

Timeline

Start
2025-05-01
Primary completion
2026-12-31
Completion
2027-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Megestrol Acetate Other / unclassified Oral